One of the three arrows of anti-aging treatment: Adipose-derived stem cell culture supernatant treatment reservation sold out
Among the three anti-aging arrows that we at JURAKU Internal Medicine Clinic started this year,
the most recent one is
the infusion therapy of human-derived mesenchymal stem cell culture supernatant.
Regarding the adipose-derived stem cells, we will end the current handling (total of 114 cells so far).
I explained the reason why I chose adipose-derived stem cells first
among human-derived mesenchymal stem cells
in my previous director’s diary (February 3, 5, 9, 2023).
It was particularly important that
extracellular secretory vesicles (EVs) secreted from adipose tissue contain eNAMPT,
an NMN (nicotinamide mononucleotide)-producing enzyme.
As one of the three arrows of anti-aging,
we will continue to provide treatments
using human mesenchymal stem cell-derived culture supernatant.
In the future, treatment using Wharton’s jelly,
that is, the culture supernatant of umbilical cord-derived stem cells, will become mainstream.
It contains 10 times more exosomes than fat-derived, so you can expect more effects.
